KUMAR AMIT 4
4 · Anixa Biosciences Inc · Filed Sep 16, 2022
Insider Transaction Report
Form 4
KUMAR AMIT
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2022-09-15$4.48/sh−491,900$2,203,712→ 462,100 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-09-15−640,000→ 0 totalExercise: $2.58From: 2012-09-19Exp: 2022-09-19→ Common Stock (640,000 underlying) - Exercise/Conversion
Common Stock
2022-09-15$2.58/sh+640,000$1,648,000→ 954,000 total
Footnotes (2)
- [F1]The reporting persons exercised the stock options at this time due to their expiration on September 19, 2022. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options.
- [F2]Right-To-Buy, pursuant to a stock option grant dated September 19, 2012.